ViewRay (VRAY) Tops Q4 EPS by 2c

ViewRay (NASDAQ: VRAY) reported Q4 EPS of ($0.25), $0.02 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $16.1 million versus the consensus estimate of $10.83 million.

"With FDA clearance in hand, we have started ramping up procurement for the new generation systems and have begun installing the first MRIdian Linac systems," said Ajay Bansal, Chief Financial Officer of ViewRay. "We expect to recognize revenue for these systems in the second half of 2017 upon system completion and acceptance."

GUIDANCE:

ViewRay sees FY2017 revenue of $45-50 million.

For earnings history and earnings-related data on ViewRay (VRAY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c